Literature DB >> 14501174

Latent autoimmune diabetes in adults (LADA).

Ramachandra G Naik1, Jerry P Palmer.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14501174     DOI： 10.1023/a:1025148211587

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  76 in total

1.  Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA).

Authors:  A Carlsson; G Sundkvist; L Groop; T Tuomi
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

Review 2.  The appropriate use of B-cell function testing in the preclinical period of type 1 diabetes.

Authors:  D K McCulloch; J P Palmer
Journal:  Diabet Med       Date:  1991-11       Impact factor: 4.359

3.  Distinct genetic and immunological features in patients with onset of IDDM before and after age 40.

Authors:  T Lohmann; J Sessler; H J Verlohren; S Schröder; J Rötger; K Dãhn; N Morgenthaler; W A Scherbaum
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

Review 4.  Classification of diabetes on the basis of etiologies versus degree of insulin deficiency.

Authors:  T Kuzuya; A Matsuda
Journal:  Diabetes Care       Date:  1997-02       Impact factor: 19.112

5.  Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.

Authors:  A Falorni; M Ackefors; C Carlberg; T Daniels; B Persson; J Robertson; A Lernmark
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

6.  Effects of insulin in relatives of patients with type 1 diabetes mellitus.

Authors: 
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

7.  Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

Authors:  C S Hampe; L P Hammerle; L Bekris; E Ortqvist; I Kockum; O Rolandsson; M Landin-Olsson; C Törn; B Persson; A Lernmark
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

8.  Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.

Authors:  H Gleichmann; B Zörcher; B Greulich; F A Gries; H R Henrichs; J Betrams; H Kolb
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

9.  Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.

Authors:  Tetsuro Kobayashi; Shoichiro Tanaka; Minoru Okubo; Koji Nakanishi; Toshio Murase; Ake Lernmark
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

10.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359
View more
  20 in total

Review 1.  Epidemiology of type 1 diabetes.

Authors:  David M Maahs; Nancy A West; Jean M Lawrence; Elizabeth J Mayer-Davis
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

2.  The common T60N polymorphism of the lymphotoxin-alpha gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome.

Authors:  Y H Hamid; S A Urhammer; C Glümer; K Borch-Johnsen; T Jørgensen; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

Review 3.  Interventions for latent autoimmune diabetes (LADA) in adults.

Authors:  Sinead Brophy; Helen Davies; Sopna Mannan; Huw Brunt; Rhys Williams
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

4.  Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method.

Authors:  Betty Tao; Massimo Pietropaolo; Mark Atkinson; Desmond Schatz; David Taylor
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

5.  Prevalence and correlates of latent autoimmune diabetes in adults in Tianjin, China: a population-based cross-sectional study.

Authors:  Xiuying Qi; Jing Sun; Jing Wang; Peizhong Peter Wang; Zhongliang Xu; Madonna Murphy; Junting Jia; Jianhua Wang; Yun Xie; Weili Xu
Journal:  Diabetes Care       Date:  2010-09-27       Impact factor: 19.112

Review 6.  Syndromes of ketosis-prone diabetes mellitus.

Authors:  Ashok Balasubramanyam; Ramaswami Nalini; Christiane S Hampe; Mario Maldonado
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

7.  Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities Study.

Authors:  A Vigo; B B Duncan; M I Schmidt; D Couper; G Heiss; J S Pankow; C M Ballantyne
Journal:  Braz J Med Biol Res       Date:  2007-07       Impact factor: 2.590

8.  GAD65 autoantibodies and its role as biomarker of Type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA).

Authors:  Roberto Towns; Massimo Pietropaolo
Journal:  Drugs Future       Date:  2011-11       Impact factor: 0.148

9.  Prevalence and clinical characteristics of recently diagnosed type 2 diabetes patients with positive anti-glutamic Acid decarboxylase antibody.

Authors:  Yul Hwangbo; Jin Taek Kim; Eun Ky Kim; Ah Reum Khang; Tae Jung Oh; Hak Chul Jang; Kyong Soo Park; Seong Yeon Kim; Hong Kyu Lee; Young Min Cho
Journal:  Diabetes Metab J       Date:  2012-04-17       Impact factor: 5.376

10.  A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes.

Authors:  Steven Edelman; George Dailey; Thomas Flood; Louis Kuritzky; Susan Renda
Journal:  Osteopath Med Prim Care       Date:  2007-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.